Navigation Links
Low levels of key protein may indicate pancreatic cancer risk
Date:8/15/2007

BOSTON--A protein that dwindles in response to obesity and a sedentary lifestyle may one day help doctors predict which people are at increased risk for pancreatic cancer, new research by Dana-Farber Cancer Institute and collaborating scientists indicates.

In a report in the Aug. 15 issue of Cancer Research, the investigators found that, in a large study group, people with the lowest blood levels of a protein called IGFBP-1 were twice as likely to develop pancreatic cancer as those with higher levels. Though much work remains to determine if the protein -- whose acronym stands for insulin-like growth factor binding protein-1 -- is a reliable indicator of pancreatic cancer risk, the finding adds to the scientific understanding of how the disease develops.

"The levels of insulin and another circulating hormone, insulin-like growth factor or IGF, are modified by obesity and sedentary lifestyle, and there is evidence that these hormones may stimulate the growth of pancreatic cancer cells," said the study's lead author, Brian Wolpin, MD, of Dana-Farber. "When IGF binds to proteins like IGFBP-1, there may be less IGF available to bind to pancreatic cancer cells and promote their growth. We wanted to determine whether IGFBP-1 levels in the blood were associated with pancreatic cancer risk."

The investigators measured circulating IGFBP-1 levels in a select group of participants in four large, ongoing health studies: the Health Professionals Follow-up Study, the Nurses' Health Study, the Physicians' Health Study, and the Women's Health Initiative. They collected blood samples from 573 participants and, four or more years later, checked IGFBP-1 levels in the samples of 144 people who developed pancreatic cancer and 429 who did not.

They found that the quarter of the group whose IGFBP-1 levels were lowest had twice the risk of developing pancreatic cancer of those in the top three quarters. The connection became even stronger over time:
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. New lab technique identifies high levels of pathogens in therapy pool
2. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
3. MERIS monitoring tracks planetary photosynthesis levels
4. High carbon dioxide levels spur Southern pines to grow more needles
5. Enzyme affects hypertension by controlling salt levels in body
6. Field tested: Grasslands wont help buffer climate change as carbon dioxide levels rise
7. Babys genes affect moms cholesterol levels
8. Males with elevated levels of testosterone lead shorter lives but have more success siring offspring
9. Salmonella bacteria use RNA to assess and adjust magnesium levels
10. Fish on acid: Hagfish cope with high levels of CO2
11. High estrogen levels associated with dementia in older men

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...swire/ -- What,s the cost of saving a teenage life...ulting from prescription medication abuse, there,s...er, may be unaware that the lock-boxes they,ve ins...king timebomb of prescription drugs. That,s why ME...ical supplies, has formed an exclusive partnership...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
(Date:11/3/2009)...report published in a recent issue of HortTechnol...amined the effects of covering orchard floors with...anopy light distribution, orchard temperature, and...ng Extenday and Solarmate films installed 5 weeks ...Gala, apples. The research showed that the use of ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Reflective film can boost profits for apple growers 2After Neuroblastoma Chronic Problems Often Await 53387 1District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 53383 1District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 53383 2Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 1Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 2
...thwestern University have pinpointed a brain area ...ting speculation over the purpose of sleep and its...aper to be published June 8 by the journal Nature,... neurobiology and physiology, shows that the so-ca...ation in the fruitfly Drosophila melanogaster. (In...
...or women who are extremely obese may be underestim...revalence of hypertension, diabetes, and high chol...ording to a study in the July 5 issue of JAMA. , O... on body mass index (BMI) of at least 30. BMI is c... in meters squared. However, three categories of o...
...ls, prized for their astonishing ability to appare...acquire their identities in part by interacting wi... of the body in a laboratory dish, University of F... of embryonic stem cell development, researchers w...swer one of the most fundamental questions in scie...
Other Biology News:Higher levels of obesity associated with greater health risks 2Higher levels of obesity associated with greater health risks 3Birds going extinct faster due to human activities 2Birds going extinct faster due to human activities 3
(Date:11/6/2009)... , The agenda for Arrowhe... Conference, which is set to take place on Februar... At this three day conference we will highlight ke...st speakers to share their experiences. , ...6, 2009 -- The agenda for Arrowhead’s 2010 ...
(Date:11/5/2009)... , PARSIPPANY, N.J., Nov. 5 D... has made a manufacturing alliance with Galenix, S...referred commercial scale manufacturing partner fo..., DSM and Galenix will collaborate on business ...g delivery technologies, based on the strength of ...
(Date:11/5/2009)... , OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/...today announced financial results for the quarter ...results are presented in the tables that follow. ,...ed a net loss of $366,000 or $0.01 per share for t... of $499,000 or $0.01 per share for the third quar...
(Date:11/5/2009)... , SAN DIEGO, CA, November 5, 2009 /PRNewswir...company focused on using proprietary taste recepto...edients for the food, beverage, and ingredient sup...and reported financial results for the third quart...illion for the third quarter of 2009, compared to ...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTI...ed Dutch Auction" tender offer (the "Exchange Offe...er to exchange shares of its common stock, no par ...ate of up to $89.2 million principal amount of the...otes (the "Notes"): , , , , 4% Converti...
...re ALS Community to Join a Nationwide Network of I... 18 The ALS Therapy Development Institute (ALS TD...ional initiative designed to increase the awarenes...lerosis), otherwise known as Lou Gehrig,s disease....her three undoubtedly American activities on July ...
...ilip Cohen,s groundbreaking research into new drug...ion at BIO 2009 , , ATLANTA, May 18 At this y...tlanta, Scotland will showcase the commercial succ...rmaceutical and biotech companies, as well as majo...overy, translational medicine, medical technology ...
Other Biology Technology:Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 2Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 3Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 4Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 5Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research 2Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research 3
... is used to quantitate double-stranded DNA (dsDNA)...in. With this kit, DNA is stained with Hoechst 332... other fluorometer. The kit quantitates dsDNA in t...d contains Hoechst 33258, calf thymus DNA standard...
...rise-scale sequence analysis software with the DeC...tensive bioinformatics analyses. With DeCypher, yo...p: BLAST 300,000 ESTs vs NCBI NT database in unde...nomic DNA Use HMM analysis to compare 100,000 se...
MagNA Pure LC Instrument from Roche Applied Science
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: